Awarded contract

The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables

  • Medicines Discovery Catapult

F15: Voluntary ex ante transparency notice

Notice reference: 2021/S 000-028616

Published 16 November 2021, 3:45pm



Section one: Contracting authority/entity

one.1) Name and addresses

Medicines Discovery Catapult

Block 35, Mereside, Alderley Park

Cheshire

SK10 4ZF

Contact

Ms Laura Hough

Email

laura.hough@md.catapult.org.uk

Telephone

+44 1625708394

Country

United Kingdom

NUTS code

UKD62 - Cheshire East

Internet address(es)

Main address

https://md.catapult.org.uk/

Buyer's address

https://md.catapult.org.uk/

one.4) Type of the contracting authority

Other type

Research - Medical

one.5) Main activity

Other activity

Research - Medical


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables

Reference number

DN578493

two.1.2) Main CPV code

  • 38000000 - Laboratory, optical and precision equipments (excl. glasses)

two.1.3) Type of contract

Supplies

two.1.4) Short description

The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £300,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKD62 - Cheshire East

two.2.4) Description of the procurement

The Supply, Delivery and Maintenance of a Illumina NextSeq 1000 Sequencing System and Associated Consumables to the Medicines Discovery Catapult Ltd.

The Illumina NextSeq 1000 Sequencing System is an integrated system for automated generation of DNA clonal clusters by bridge amplification, sequencing, primary analysis, and secondary analysis. The system includes embedded touchscreen monitor and on-instrument computer, control software, hardware accelerated analysis pipelines. The contract includes delivery, installation, maintenance and training. The associated consumables are also included in the scope of this contract.

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Negotiated without a prior call for competition

  • The works, supplies or services can be provided only by a particular economic operator for the following reason:
    • absence of competition for technical reasons

Explanation:

The Illumina sequencer for GeoMx is required by the Medicines Discovery Catapult Ltd (MDC) as it forms part of the GeoMx workflow for whole spatial transcriptome analysis.

Illumina sequencer for GeoMx is required, there is no competition and competition is absent for technical reasons as the Illumina sequencer for GeoMx is the only instrument which has access to Illumina adapters within the nanostring reagents. Nanostring have developed a workflow with Illumina where Illumina’s i5 and i7 sequences specifically add P5 and P7 sequences for binding to Illumina’s flow cell.

These sequences are part of the SeqCode that are for the library prep and there are no alternative sequences to obtain for analysis.

Furthermore, the software offers a selection of Illumina sequencers to choose from when finalizing the readout group (to be able to start sequencing) – this will create files that are tailored towards use on the respective Illumina platforms. Most of all, the sequences (FASTQ files) need to be processed in order to be made compatible with the GeoMx for import. The pipeline software is tailored to work with the Illumina output files (including Illumina’s index sequences) and cannot be used on sequences produced by any other system. Or you can directly process these files within Illumina’s BaseSpace environment.

The purchase of the equipment will enable a fully integrated workflow of the two systems.

The MDC will follow a 10 day standstill period ending on midnight on Friday 26th November 2021. Following the successful completion of the standstill period the MDC will award the contract to Illumina Cambridge Ltd.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract/concession

A contract/lot is awarded: Yes

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract

16 November 2021

five.2.2) Information about tenders

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

Illumina Cambridge Ltd

Essex

Country

United Kingdom

NUTS code
  • UKD62 - Cheshire East
The contractor/concessionaire is an SME

No

five.2.4) Information on value of contract/lot/concession (excluding VAT)

Total value of the contract/lot/concession: £300,000


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Medicines Discovery Catapult

Alderley Edge

Country

United Kingdom